# Study of Rebamipide Eye Drops to Treat Dry Eye

> **NCT00201955** · PHASE3 · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 740 (—)

## Conditions studied

- Keratoconjunctivitis Sicca

## Interventions

- **DRUG:** Rebamipide

## Key facts

- **NCT ID:** NCT00201955
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 740 (—)
- **Last updated:** 2006-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00201955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00201955, "Study of Rebamipide Eye Drops to Treat Dry Eye". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00201955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*